Rho Capital Partners

Latest statistics and disclosures from Rho Capital Partners's latest quarterly 13F-HR filing:

Companies in the Rho Capital Partners portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Cara Therapeutics 76.67 3.57M 15.39
Mersana Therapeutics 15.96 NEW 818033 13.97
Inotek Pharmaceuticals 6.97 2.63M 1.90
Senseonics Hldgs 0.40 159601 1.80

Past 13F-HR SEC Filings by Rho Capital Partners

View All Filings